This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.
Sleep is important for everyone, including youth with type 1 diabetes. New technology has shown improvements in glycemic variability, especially overnight. This study evaluates the impact of advanced hybrid closed-loop insulin delivery systems on sleep for both youth with type 1 diabetes and their parents. Study measures include wearing an actigraphy watch and completing a sleep diary for 7 days and taking surveys on sleep and psychosocial measures. Study measures occur prior to starting the hybrid closed-loop system, immediately after starting the system and at 3 and 6 months after starting the system.
Study Type
OBSERVATIONAL
Enrollment
46
University of Colorado, Barbara Davis Center
Aurora, Colorado, United States
Duration of Sleep
Change in duration of sleep before and after starting the advanced hybrid closed-loop system using surveys and activity watches
Time frame: End of study (6 months)
Impact on Diabetes Distress
Change in diabetes-related distress using the validated Problem Areas in Diabetes survey
Time frame: End of study (6 months)
Impact on Quality of Life
Change in quality of life using the validated survey Pediatric Quality of Life Inventory Diabetes Module (PedsQL)
Time frame: End of study (6 months)
Impact on Fear of Hypoglycemia
Change in fear of hypoglycemia using the validated hypoglycemia fear survey
Time frame: End of study (6 months)
Impact on Perceptions of Diabetes Technology
Change in diabetes technology perceptions using the validated survey Diabetes Technology Questionnaire
Time frame: End of study (6 months)
Impact on Hybrid Closed-Loop System Use Perceptions
Change in perceptions of hybrid-closed loop systems using the validated INSPIRE survey
Time frame: End of study (6 months)
Impact of Sleep on Glycemic Variability
Correlation of sleep duration and glycemic variability using hybrid closed loop device download to analyze time in range, time with low glucose and time with high glucose
Time frame: End of study (6 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.